CFO & EVP of Corp. Development · Milestone Pharmaceuticals Inc. · Common Shares
Side
A
Value
—
Shares
100.0K
Price
—
Executed
Dec 12, 2025
Disclosed
Jan 28, 2026
Disclosure timeline47 days from execution to publication · legal deadline 2 business days
Dec 12 executedJan 28, 2026 disclosed
MIST · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 200.0% of prior position
Filing timing+15 / 15
Disclosed 33 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Hasija Amit filed this Form 4 reporting a grant or award of MIST on Dec 12, 2025. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
CFO & EVP of Corp. Development
Hasija Amitcik:0001787700
Issuer
Milestone Pharmaceuticals Inc.cik:0001408443
Revision history · 0
No field has changed since this record was first ingested.
